Latest News

Latest News

Twin B7-H3 ADC Wins in Seoul Leave the UK Route Unresolved

Twin B7-H3 ADC Wins in Seoul Leave the UK Route Unresolved

Two B7-H3 ADC readouts landed in the same Seoul session on 13 September 2026. Both reported a survival win in relapsed small cell lung cancer. Both trials ran entirely in China. Neither dataset, on its own, is a filing package for the FDA, the EMA or the MHRA. Two...

read more

Join The Future Of Life Sciences Media

 

In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters, all in real time.

 

 

Don’t wait for the media to pick up your story. Be the media.

More News

Global Funding Shifts Redraw Life Sciences Innovation Map

Global Funding Shifts Redraw Life Sciences Innovation Map

The life sciences sector is experiencing a fundamental reshaping of its innovation geography as funding pressures, policy shifts, and geopolitical tensions redraw the competitive landscape across continents. While research funding constraints in the United States...

read more
Medical Bankruptcy: The Hidden Cost of U.S. Health Care

Medical Bankruptcy: The Hidden Cost of U.S. Health Care

My wife underwent major surgery in December 2025. She remained 10 days in a Charlotte, NC, hospital and was then for several weeks supported at home by visiting nurses, a physical therapist and a dietician. We just saw the bill: The hospital and participating doctors...

read more
Pregnancy, the Brain, and the Nervous System

Pregnancy, the Brain, and the Nervous System

Pregnancy, the Brain, and the Nervous System: A Holistic Perspective on Perinatal Mental Health Pregnancy is often framed as a joyful milestone, yet from a clinical and neurobiological standpoint, it is one of the most significant periods of transformation a human...

read more
Global Funding Shifts Redraw Life Sciences Innovation Map

Global Funding Shifts Redraw Life Sciences Innovation Map

The life sciences sector is experiencing a fundamental reshaping of its innovation geography as funding pressures, policy shifts, and geopolitical tensions redraw the competitive landscape across continents. While research funding constraints in the United States...

read more
Medical Bankruptcy: The Hidden Cost of U.S. Health Care

Medical Bankruptcy: The Hidden Cost of U.S. Health Care

My wife underwent major surgery in December 2025. She remained 10 days in a Charlotte, NC, hospital and was then for several weeks supported at home by visiting nurses, a physical therapist and a dietician. We just saw the bill: The hospital and participating doctors...

read more
Pregnancy, the Brain, and the Nervous System

Pregnancy, the Brain, and the Nervous System

Pregnancy, the Brain, and the Nervous System: A Holistic Perspective on Perinatal Mental Health Pregnancy is often framed as a joyful milestone, yet from a clinical and neurobiological standpoint, it is one of the most significant periods of transformation a human...

read more

Featured Articles

DNA double helix beside a microscope, test tubes and a pipette over a petri dish, representing life science publishing

Life Science Publishing: Our First Year, and Where You Fit In

Almost a year ago, Life Science Daily News published its first articles with a simple belief. Specialist science deserves a specialist stage. Since then, that belief has grown into a global readership and an active community of contributors. This is the story of our...
FDA building exterior alongside pharmaceutical laboratory setting representing drug approval decisions

FDA Drug Approval Decisions

Last updated 28 October 2026. Covering target action dates from October 2026 to February 2027. October changed how this tracker has to be read. Six FDA drug approval decisions landed in the month, and four arrived ahead of target. One cleared roughly 12 weeks early,...
gloved hands holding a glowing blue sample vial (labelled LOT: 24-B1, SAMPLE: GENO-) with a lab researcher working in the background.

CRISPR Gene Editing 2026: Rare Diseases, Cancer and Autoimmune

CRISPR gene editing in 2026 is no longer a technology to watch. It is a technology delivering results. Across three distinct disease areas, rare inherited conditions, haematologic and solid cancers, and autoimmune disease, clinical programmes are accumulating...
Three GLP-1 drug pipeline injection pens and oral tablets beside a clinical trial efficacy chart on a clipboard

The GLP-1 Drug Pipeline: Every Candidate to Watch in 2026

The GLP-1 drug pipeline has become one of the most consequential and closely watched in modern pharmaceutical history. In 2026, the class of glucagon-like peptide-1 receptor agonists is no longer defined solely by Ozempic and Wegovy. A new generation of oral tablets,...
Sjögren's disease diagnosis: close-up of a dry, irritated eye with eye drops being applied

Anti-Ro52 vs Anti-Ro60: Advancing Sjögren’s Disease Diagnosis

Autoantibody testing is a central part of autoimmune disease diagnosis, including Sjögren’s disease (SjD). The American College of Rheumatology and European Alliance of Associations of Rheumatology (ACR/EULAR) classification criteria for SjD incorporate ocular and...

Further News

UK Expertise: Faster Cancer Diagnosis and Cleaner Energy

UK Expertise: Faster Cancer Diagnosis and Cleaner Energy

British research expertise to deliver faster cancer diagnosis and cleaner energy Major new backing for medical imaging centres across the UK alongside tidal energy testing expansion in Orkney and cutting-edge materials. From:  Department for Science, Innovation and...

read more
NIH Scientists Pioneer “Digital Twin” of Eye Cells

NIH Scientists Pioneer “Digital Twin” of Eye Cells

NIH Scientists Pioneer “Digital Twin” of Eye Cells: A New Frontier in Treating Age-Related Macular Degeneration In a landmark achievement for computational biology and ophthalmology, researchers at the National Institutes of Health (NIH) have announced the development...

read more
AuDHD: Rethinking the Overlap Between Autism and ADHD

AuDHD: Rethinking the Overlap Between Autism and ADHD

A Diagnostic Separation That Shaped a Generation For most of the modern history of psychiatry, autism and ADHD were treated as mutually exclusive conditions. Clinicians were trained to look for one or the other. Until the publication of DSM-5 in 2013, a dual diagnosis...

read more
FDA Approves Commercial Manufacturing at Rezon Bio

FDA Approves Commercial Manufacturing at Rezon Bio

Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufacturing of a biosimilar. This milestone represents an important step in the continued development of Rezon Bio's...

read more
Uniphar | Clinical merges with BMclinical

Uniphar | Clinical merges with BMclinical

Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and...

read more

Further News

Receptor.AI and Sethera Partner on AI-Guided Peptide Drug Discovery

Receptor.AI and Sethera Therapeutics Form Integrated Discovery Alliance for AI-Guided Polymacrocyclic Peptide Medicines Collaboration combines Sethera's proprietary enzymatic polymacrocyclisation and trillion-scale encoded screening with Receptor.AI's physics-based...

Dual and Triple Agonists Explained: GLP-1, GIP and Glucagon

Obesity and diabetes medicine has moved a long way from the single-hormone era. Dual and triple agonists are engineered molecules that switch on two or three hormone receptors at once. They now dominate the late-stage pipeline, and the highest doses tested have...

Ziltivekimab ZEUS Trial: What the Null Result Means

The ziltivekimab ZEUS trial has produced one of the more instructive negative results in recent cardiovascular medicine. Novo Nordisk announced headline results on 31 July 2026 showing that its once-monthly interleukin-6 inhibitor ziltivekimab lowered inflammation...

How the Gut-Brain-Metabolism Axis Is Reshaping Targeted Therapy

For decades, the fields of oncology, neuroscience, and microbiology operated in distinct silos within therapeutic research and clinical practice. Modern drug discovery, however, is rapidly witnessing a paradigm shift toward systemic biology. Researchers increasingly...

Singapore Radiopharmaceutical Market: How H2 2026 Looks

The Singapore radiopharmaceutical market enters the second half of 2026 with more clinical capacity, more research output and a heavier regulatory calendar than at any previous point. New imaging infrastructure came online at the end of 2025, first-in-human data from...

Why True Health Foods Need Evidence, Not Fashion

Functional foods have entered the mainstream, but adding a recognised ingredient is not the same as creating a credible product. A cardiologist argues that the category’s next phase will be won on scientific rationale, dose and honest communication, not on the length...

How Clinical Research Is Transforming the Future of Sarcoma Care

Rare cancers present one of the greatest challenges in modern oncology. Individually uncommon but collectively accounting for around one in five cancer diagnoses worldwide, they have historically attracted less research funding, fewer clinical trials and limited...

Weekly News Roundup | 03 August 2026

Life science news 3 August 2026: argenx pays $2.2 billion for what it calls a first-in-class anti-CD122 antibody, Johnson & Johnson strikes agreements worth up to $3.5 billion with in vivo CAR-T developer Sail Biomedicines, and GSK launches a £1.9 billion savings...

Personalized Cancer Care: How the Immune System is Reshaping Oncology

Immuno-oncology is not a new frontier, and for years, therapies like checkpoint inhibitors have reshaped how we treat certain cancers. While early approaches established that the immune system could fight cancer, the field has seen both major breakthroughs and clear...

FDA PreCheck Program: Seven Companies Chosen to Reshape US Manufacturing

The United States Food and Drug Administration has selected seven pharmaceutical and biotechnology companies for its FDA PreCheck Program, a pilot initiative designed to accelerate the establishment of new domestic drug manufacturing facilities. Announced on 7 August...

Retatrutide Phase 3 Data: Record Weight Loss, Unanswered Questions

Retatrutide, Eli Lilly’s investigational triple hormone receptor agonist, has now reported positive results across five Phase 3 trials. In the pivotal TRIUMPH-1 obesity study, participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks,...

Responsible AI in Healthcare: Building Trust for Clinical Innovation

Artificial intelligence (AI) is rapidly transforming healthcare, moving beyond research laboratories into hospitals, clinics, and public health systems worldwide. Today, AI supports clinicians in areas such as medical imaging, clinical documentation, decision support,...

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.

See More Articles

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.